GILD vs TECH · P/E 18, rev $29.44B vs P/E 65, rev $1.22B
Gilead Sciences Inc (GILD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GILD and TECH stock pages for the full models.
Not investment advice.